VetIQ Hip & Joint is a low-cost, chicken-flavored soft chew sold mainly through Walmart, Chewy and Sam’s Club. PetIQ’s own product page describes it as built on “glucosamine, omegas, and MSM,” and — importantly — publishes no per-serving amounts for any of them. Whether the product helps your dog depends far less on the brand than on which of those ingredient classes actually have evidence behind them in dogs, and on that question the honest answer is that the omega-3 fraction is the part with the strongest research support, while the glucosamine that dominates the marketing has repeatedly underperformed in controlled canine trials.
Quick answer: VetIQ Hip & Joint is a budget joint chew whose manufacturer page lists glucosamine, omegas and MSM without disclosing how much of each a serving contains. Research suggests omega-3 fatty acids are the best-supported nutraceutical for canine osteoarthritis; a 2022 systematic review and meta-analysis reported “a very marked non-effect” for chondroitin–glucosamine products (Barbeau-Grégoire et al., Int J Mol Sci 2022). Supplements of any brand are a supporting measure, not a substitute for veterinary diagnosis, weight management or prescribed pain control.
What is actually in VetIQ Hip & Joint?
Less than you can easily check, and that is the first finding worth reporting. As of August 2026 the manufacturer’s page for VetIQ Hip & Joint names three active categories — glucosamine, omegas and MSM — with no milligram figures, no EPA/DHA split and no guaranteed analysis. Third-party listings reproducing a numeric panel could not be confirmed against the brand, so no amounts are quoted here. For the numbers, read the bottle in front of you or ask PetIQ, and treat any figure copied from a review site as unverified.
Serving size on this type of product scales with body weight, so a small dog and a large dog do not get the same totals from the same bottle. Without a per-serving panel you cannot compare this chew against the intakes used in the trials that produced results, or against a competitor on anything but price. In particular, the therapeutic-diet trials behind the omega-3 evidence used enriched diets, not treat-sized chews. Never scale a product up on your own to close a gap you cannot measure; follow the label or ask your veterinarian.
VetIQ also sells more than one Hip & Joint format, and they are not interchangeable. The soft chew is marketed on glucosamine, omegas and MSM; a separate VetIQ Hip & Joint chewable tablet is marketed as containing glucosamine, chondroitin and MSM. If the glucosamine–chondroitin pairing is what you want, confirm which SKU is in your basket — our comparison of Dasuquin versus Cosequin for dogs walks through how the two-ingredient formulas are built.
Does the science support hip and joint chews?
This is where most reviews of VetIQ go quiet. Ingredient lists get copied; evidence quality rarely does. Here is how these ingredient classes sit against the published canine literature.
| Ingredient | Evidence in dogs | Strength |
|---|---|---|
| Omega-3 EPA/DHA (fish oil, krill) | Randomized, blinded, controlled trial in 127 client-owned dogs (Roush et al., JAVMA 2010) and repeated positive findings in a 2022 meta-analysis | Strong — the best-supported nutraceutical category |
| Weight loss (not in the product, but relevant) | Lameness improved measurably with modest weight reduction in obese dogs with OA (Marshall et al. 2010) | Strong |
| Green-lipped mussel | Some controlled work exists; a 2024 accelerometry pilot in working farm dogs was exploratory | Moderate to limited |
| Glucosamine (alone or with chondroitin) | 2022 systematic review and meta-analysis reported a very marked non-effect for pain in dogs and cats | Limited / negative |
| MSM | Little to no controlled canine osteoarthritis evidence published | Limited |
| Hyaluronic acid (oral) | Oral canine evidence is sparse | Anecdotal |
| Antioxidant and cofactor nutrients (e.g. vitamin E, manganese) | Supporting nutrients; no canine OA outcome trials establishing a clinical effect | Anecdotal |
The Barbeau-Grégoire meta-analysis is the single most important document for anyone shopping this category. Reviewing 57 articles and 72 trials, the authors found “an evident clinical analgesic efficacy for omega-3-enriched diets, omega-3 supplements and cannabidiol (to a lesser degree),” a weak effect for collagen, and concluded that chondroitin–glucosamine nutraceuticals “should no longer be recommended for pain management in canine and feline osteoarthritis.”
That is a strong statement, and it does not mean glucosamine is harmful. It means the burden of proof has shifted, and marketing that presents glucosamine as the proven active ingredient is running ahead of the data. Our longer explainer on how glucosamine works in dogs covers the mechanism and the trial history in more detail.
There is a second, quieter problem: label accuracy. Asthana and colleagues (PLoS One, 2019) developed and validated an HPLC method for quantifying glucosamine in dietary supplements — analytical work that exists precisely because supplement content is not verified the way prescription drugs are. Human and veterinary supplements alike sit in a lightly regulated space, so a number on a panel is a claim, not a guarantee, and an absent number is not even that. Products carrying the NASC Quality Seal have at least submitted to third-party auditing, which is one of the few practical quality filters a shopper has. Ratsch, Levine and Wakshlag’s 2022 clinical guide to nutraceuticals in canine orthopedic conditions makes the same point from the clinician’s side: product selection has to account for a market where quality and disclosure vary widely. We cover that filter, and others, in our guide to dog joint supplements.
Two checks follow. Does the brand publish a per-serving panel, and does it carry a third-party quality seal? A product failing both is not necessarily bad — it is simply one you cannot evaluate on anything but taste and price.
What can a hip and joint chew realistically do — and not do?
A simple decision framework helps more than another star rating.
| Situation | Is a joint chew the right tool? |
|---|---|
| Healthy adult dog, no signs, breed at risk of hip dysplasia | Reasonable as a low-risk addition; expect nothing dramatic and keep body condition lean |
| Mild stiffness after rest, otherwise normal | Possibly helpful alongside a veterinary exam to confirm what you’re treating |
| Visible limping, reluctance on stairs, yelping | No — this needs a diagnosis first; a chew may mask nothing and delay real care |
| Overweight dog with joint signs | Weight management first; it has better evidence than any supplement in this category |
| Dog already on NSAIDs or other prescriptions | Ask your veterinarian before adding anything, including fish oil |
| Sudden non-weight-bearing lameness | Urgent veterinary care, not a supplement decision |
A chew of this type may support normal joint comfort and mobility as part of a broader plan. It cannot diagnose, treat or reverse osteoarthritis, cannot rebuild eroded cartilage, and cannot replace pain medication in a dog that needs it. If your dog is at the point of needing pharmacological help, our overview of arthritis medicine options for dogs explains what your veterinarian is likely to discuss.
How long before you see anything?
Owner reviews on retail sites frequently describe improvement “within days.” Physiologically, that timing is hard to explain for glucosamine or omega-3, both of which act slowly if at all, and it overlaps heavily with normal day-to-day variation in a dog’s comfort and with owner expectation. A more realistic frame:
- Weeks 1–2: Palatability and tolerance become clear. Loose stool or reduced appetite is the most common early complaint with oily chews. Nothing meaningful should be read into mobility at this stage.
- Weeks 4–8: In the trials that did show benefit, omega-3 effects on clinical signs emerged over a period of weeks to months, not days. This is the earliest window in which a genuine change is plausible.
- Beyond 8–12 weeks: If there is no observable difference in stair use, rising from rest, or willingness to walk, the honest conclusion is that this product is not doing much for this dog.
Track something objective: video your dog rising from a lie-down on the same surface weekly, or count stairs taken before a pause. Memory is a poor instrument for slow change.
Common mistakes owners make
Treating a limp as a supplement problem. Cruciate ligament rupture, immune-mediated joint disease, tick-borne infection and bone tumours all present as lameness. A chew does not distinguish them.
Doubling up on omega-3 sources. Adding a separate fish oil on top of a joint chew, an omega-enriched food and a skin supplement can stack up. Fish oil at high intakes has been associated with GI upset and altered platelet function; your veterinarian should be the one doing that arithmetic.
Assuming shellfish glucosamine is fine for a shellfish-sensitive dog. True shellfish allergy in dogs is uncommon but not impossible, and this product’s glucosamine is shellfish-derived.
Ignoring body condition. The single best-supported intervention for canine osteoarthritis in this literature is not on any supplement label. Marshall and colleagues found lameness decreased significantly after relatively modest weight reduction in obese dogs with OA, with objective gait analysis confirming it. Mlacnik and colleagues found caloric restriction combined with physiotherapy improved mobility over six months.
Choosing on price per bottle rather than price per serving. Because larger dogs take more chews per day, a cheap 180-count bottle can be more expensive per month than it looks. Our roundup of hip and joint chews for dogs compares products on that basis.
When to call your vet
Contact your veterinarian promptly if your dog shows any of the following, rather than reaching for a supplement:
- Sudden lameness, or refusal to bear weight on a limb
- Yelping, guarding, or a change in temperament around handling
- Swollen, hot or visibly deformed joints
- Lameness with fever, lethargy or loss of appetite
- Rapid worsening over days rather than gradual change over months
- Vomiting, diarrhoea, black stools or appetite loss after starting any new supplement
- Any joint sign in a dog already taking NSAIDs, corticosteroids or anticoagulant medication
Osteoarthritis is one of the most common chronic painful conditions recognised in dogs, and veterinary teams now have staging tools and multimodal plans that go well beyond what a chew can offer.
FAQ
Is VetIQ Hip & Joint a good supplement for dogs?
It is an inexpensive, widely available chew. Its evidence profile is mixed: the omega-3 fraction has the strongest research support of anything named on the label, while glucosamine and MSM have weak canine evidence. The manufacturer’s page does not publish per-serving amounts, which limits how far anyone can assess it.
Does VetIQ Hip & Joint contain chondroitin?
It depends on the format. The soft chew is marketed on glucosamine, omegas and MSM, while a separate VetIQ Hip & Joint chewable tablet is marketed as containing glucosamine, chondroitin and MSM. Check the specific pack you are buying.
How much glucosamine is in VetIQ Hip & Joint?
The manufacturer’s product page does not state a per-serving amount. Read the guaranteed analysis printed on the bottle, or contact PetIQ, rather than relying on figures reproduced by third-party sites.
How long does VetIQ Hip & Joint take to work?
Manufacturers of this category generally suggest several weeks. In the canine trials that showed benefit from omega-3s, changes in clinical signs emerged over weeks to months. Judge the product at eight to twelve weeks, not eight days.
Can I give VetIQ Hip & Joint with my dog’s arthritis medication?
Ask your veterinarian first. Interactions and additive GI effects are possible, and your vet may want to account for omega-3 intake from all sources.
Is glucosamine safe for dogs?
Glucosamine is generally well tolerated in dogs, with GI upset the most commonly reported effect. Dogs with diabetes, bleeding disorders, or shellfish sensitivity, and pregnant or nursing dogs, warrant a veterinary conversation first.
References
- Barbeau-Grégoire M, Otis C, Cournoyer A, Moreau M, Lussier B, Troncy E. A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. Int J Mol Sci. 2022;23(18):10384. DOI: 10.3390/ijms231810384. PMID: 36142319. https://pubmed.ncbi.nlm.nih.gov/36142319/
- Roush JK, Dodd CE, Fritsch DA, et al. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. J Am Vet Med Assoc. 2010;236(1):59–66. DOI: 10.2460/javma.236.1.59. PMID: 20043800. https://pubmed.ncbi.nlm.nih.gov/20043800/
- Marshall WG, Hazewinkel HA, Mullen D, De Meyer G, Baert K, Carmichael S. The effect of weight loss on lameness in obese dogs with osteoarthritis. Vet Res Commun. 2010;34(3):241–253. DOI: 10.1007/s11259-010-9348-7. PMID: 20237844. https://pubmed.ncbi.nlm.nih.gov/20237844/
- Mlacnik E, Bockstahler BA, Müller M, Tetrick MA, Nap RC, Zentek J. Effects of caloric restriction and a moderate or intense physiotherapy program for treatment of lameness in overweight dogs with osteoarthritis. J Am Vet Med Assoc. 2006;229(11):1756–1760. DOI: 10.2460/javma.229.11.1756. PMID: 17144822. https://pubmed.ncbi.nlm.nih.gov/17144822/
- Cave N, Bolton S, Cogger N. A pilot study to detect the effects of a green-lipped mussel (Perna canaliculus) nutraceutical on working farm dogs with musculoskeletal abnormalities using accelerometry. N Z Vet J. 2024;72(6):323–333. DOI: 10.1080/00480169.2024.2379966. PMID: 39112015. https://pubmed.ncbi.nlm.nih.gov/39112015/
- Asthana C, Peterson GM, Shastri M, Patel RP. Development and validation of a novel high performance liquid chromatography-coupled with Corona charged aerosol detector method for quantification of glucosamine in dietary supplements. PLoS One. 2019;14(5):e0216039. DOI: 10.1371/journal.pone.0216039. PMID: 31059544. https://pubmed.ncbi.nlm.nih.gov/31059544/
- Ratsch BE, Levine D, Wakshlag JJ. Clinical Guide to Obesity and Nonherbal Nutraceuticals in Canine Orthopedic Conditions. Vet Clin North Am Small Anim Pract. 2022;52(4):939–958. DOI: 10.1016/j.cvsm.2022.03.002. PMID: 35562213. https://pubmed.ncbi.nlm.nih.gov/35562213/
- Merck Veterinary Manual. Osteoarthritis in Dogs and Cats. https://www.merckvetmanual.com/musculoskeletal-system/osteoarthritis-in-dogs-and-cats/osteoarthritis-in-dogs-and-cats
- PetIQ, LLC. Vet IQ Hip & Joint Soft Chews for Dogs (manufacturer product page; ingredient categories only, no per-serving amounts published, accessed 23 August 2026). https://vetiq.com/products/hip-joint
Veterinary disclaimer
This article is for general educational purposes and is not veterinary advice. Dog Health Insider is an independent publication and is not affiliated with VetIQ or any supplement manufacturer. Nothing here is intended to diagnose, treat, cure or prevent any disease. Always consult a licensed veterinarian before starting, stopping or combining any supplement or medication, and follow the dosing instructions on your product label or those given by your veterinarian.